About 20 pharmas including Hanmi Pharm compete in antithrombotic market
As ‘Brilinta Tab(generic name: ticagrelor),’a AstraZeneca’s antithrombotic, is expired in its PMS(Post-Marketing Surveillance), about 20 Korean pharmaceutical companies including Hanmi Pharm jumped into its market after getting generic approval.
According to the Ministry of Food and Drug Safety(...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
